| # | Title | Journal | Year | Citations |
|---|
| 1 | Estradiol in elderly men | Aging Male | 2002 | 365 |
| 2 | Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency | Aging Male | 2003 | 322 |
| 3 | Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies | Aging Male | 2020 | 311 |
| 4 | A new ‘aging males’ symptoms' rating scale | Aging Male | 1999 | 295 |
| 5 | Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men | Aging Male | 2015 | 249 |
| 6 | Active Ageing: A Policy Framework | Aging Male | 2002 | 225 |
| 7 | Investigation, treatment and monitoring of late-onset hypogonadism in males.Official Recommendations of ISSAM | Aging Male | 2002 | 224 |
| 8 | The relationship between circulating testosterone and inflammatory cytokines in men | Aging Male | 2019 | 179 |
| 9 | ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males | Aging Male | 2009 | 160 |
| 10 | Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone | Aging Male | 2003 | 156 |
| 11 | Progesterone: the forgotten hormone in men? | Aging Male | 2004 | 152 |
| 12 | A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer's disease | Aging Male | 2003 | 150 |
| 13 | Estradiol in elderly men | Aging Male | 2002 | 130 |
| 14 | Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study | Aging Male | 2011 | 129 |
| 15 | Investigation, treatment and monitoring of late-onset hypogonadism in males | Aging Male | 2005 | 126 |
| 16 | Life satisfaction, anxiety, depression and resilience across the life span of men | Aging Male | 2010 | 113 |
| 17 | Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction | Aging Male | 2019 | 113 |
| 18 | Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus | Aging Male | 2020 | 107 |
| 19 | Diagnosis of hypogonadism in the aging male | Aging Male | 2002 | 105 |
| 20 | The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism | Aging Male | 2008 | 104 |
| 21 | A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer's disease | Aging Male | 2003 | 104 |
| 22 | ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: Scientific background and rationale | Aging Male | 2005 | 103 |
| 23 | Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome | Aging Male | 2008 | 103 |
| 24 | Changing trends of prostate cancer in Asia | Aging Male | 2004 | 101 |
| 25 | Why can patients with erectile dysfunction be considered lucky? The association with testosterone deficiency and metabolic syndrome | Aging Male | 2008 | 101 |
| 26 | Effect of serum total testosterone and its relationship with other laboratory parameters on the prognosis of coronavirus disease 2019 (COVID-19) in SARS-CoV-2 infected male patients: a cohort study | Aging Male | 2020 | 101 |
| 27 | Frailty and the aging male | Aging Male | 2005 | 99 |
| 28 | Active Ageing: A Policy Framework | Aging Male | 2002 | 98 |
| 29 | Can results of the Aging Males' Symptoms (AMS) scale predict those of screening scales for androgen deficiency? | Aging Male | 2004 | 96 |
| 30 | Vitamin D treatment improves levels of sexual hormones, metabolic parameters and erectile function in middle-aged vitamin D deficient men | Aging Male | 2017 | 94 |
| 31 | Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes | Aging Male | 2007 | 92 |
| 32 | Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study | Aging Male | 2012 | 91 |
| 33 | Estradiol in elderly men | Aging Male | 2002 | 91 |
| 34 | Oxidative stress increases continuously with BMI and age with unfavourable profiles in males | Aging Male | 2012 | 90 |
| 35 | A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up | Aging Male | 2012 | 90 |
| 36 | Prevalence, incidence and risk factors of testosterone deficiency in a population-based cohort of men: results from the study of health in Pomerania | Aging Male | 2010 | 88 |
| 37 | Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters | Aging Male | 2016 | 88 |
| 38 | Testosterone and the brain | Aging Male | 2006 | 85 |
| 39 | Relation between hand grip strength, respiratory muscle strength and spirometric measures in male nursing home residents | Aging Male | 2014 | 84 |
| 40 | Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency | Aging Male | 2003 | 84 |
| 41 | Association between novel inflammatory markers derived from hemogram indices and metabolic parameters in type 2 diabetic men | Aging Male | 2020 | 79 |
| 42 | Association between severity of lower urinary tract symptoms, erectile dysfunction and metabolic syndrome | Aging Male | 2009 | 77 |
| 43 | Prevalence of sarcopenia and its association with functional and nutritional status among male residents in a nursing home in Turkey | Aging Male | 2010 | 74 |
| 44 | The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes | Aging Male | 2018 | 73 |
| 45 | The effect of 6 months of androgen deprivation therapy on muscle and fat mass in older men with localized prostate cancer | Aging Male | 2005 | 71 |
| 46 | Inverse association between total testosterone concentrations, incident hypertension and blood pressure | Aging Male | 2011 | 71 |
| 47 | Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: A pilot study | Aging Male | 2008 | 70 |
| 48 | Investigation, treatment and monitoring of late-onset hypogonadism in males. Official Recommendations of ISSAM | Aging Male | 2002 | 69 |
| 49 | Re-constructing masculinity following radical prostatectomy for prostate cancer | Aging Male | 2010 | 63 |
| 50 | Is erectile dysfunction predictive of peripheral vascular disease? | Aging Male | 2003 | 61 |
